ArticleOral oncology2019
PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma.
Nnamdi Eze et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled ittrialcites it